PATENT CLAIM ANALYSIS

Application Number: 16459048
Application Type: Utility
Filing Date: 2019-07
Publication Date: 2019-10
Patent Classification: ["514", "253070"]

Abstract:
The present invention provides a heterocyclic compound represented by the general formula (1): The compound of the present invention has a wide treatment spectrum for mental disorders including central nervous system disorders, no side effects and high safety.

Claim (Index 8):
The heterocyclic compound of the formula (1) according to  claim 4  selected from the group consisting of:\n (1) 7-[3-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)propoxy]-3,4-dihydro-2H-isoquinolin-1-one \n (2) 7-[3-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)propoxy]-2-methyl-3,4-dihydro-2H-isoquinolin-1-one, \n (3) 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl) butoxy]-2-methyl-3,4-dihydro-2H-isoquinolin-1-one, \n (4) 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-3,4-dihydro-2H-isoquinoline-1-one, \n (5) 7-[3-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)propoxy]-2H-isoquinolin-1-one and \n (6) 7-[3-(4-benzo[b]thiophen-4-yl-piperazin-1-yl) propoxy]-2-methyl-2H-isoquinolin-1-one; \n or a salt thereof.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 100.0
- Lexical Diversity: 1.19444
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['11659005', '15697196', '14089504', '14928972', '12970690']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8506860098872866
- 35 USC 102 Novelty (BERT): 0.6202983674259773
- Combined Prediction Score: 0.8276472456411558
- Mean Citation Score: 527.301186
- Max Citation Score: 558.7385
- Similarity Product: 551.0526724761129

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test